Tempero Bio was created in 2020 by the venture firm Aditum Bio to advance the clinical development of a portfolio of potent, ...

Carlsbad’s Ionis Pharmaceuticals struck a deal worth up to $940 million with Japan-based Ono Pharmaceutical for its medicine ...

MAGA Gov. Glenn Youngkin has, for a second straight year, vetoed legislation that would establish a Prescription Drug ...

Me's drugs and patents — including two possible deals — could be key to its exit out of Chapter 11 bankruptcy protection.

Mirum Pharmaceuticals stock surged 25% and how LIVMARLI drives growth. Explore future prospects with Volixibat. Click here to ...

Reports hint that the administration will likely omit industry-specific tariffs from its announcement April 2.

Two UIC professors list their questions for the man set to lead "the crown jewel” of American biomedical science.

The company expects next quarter to read out initial data from its Heart-2 trial, which is testing a one-time treatment for people with genetically elevated cholesterol.

In Harrington v. Purdue Pharma L.P., the Supreme Court held that the Bankruptcy Code does not authorize a bankruptcy court to ...

Impending U.S. tariffs could have a deep impact on the Irish economy and its strong reliance on pharmaceuticals and digital.

With 23andMe officially up for sale, there’s no telling who might end up owning the company — or what they’ll want with the ...

President Donald Trump has praised tariffs and announced an array of import duties on specific countries and products since ...